Literature DB >> 8575482

Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.

C Rossetti1, C Landoni, G Lucignani, G Huang, A L Bartorelli, M D Guazzi, A Margonato, S Chierchia, L Galli, A Savi.   

Abstract

We compare thallium-201 rest redistribution and fluorine-18 fluorodeoxyglucose ([18F]FDG) for the assessment of myocardial viability within technetium-99m methoxyisobutylisonitrile (MIBI) perfusion defects in 27 patients with chronic stable coronary artery disease. The following studies were performed: (1) stress 99mTc-MIBI, (2) rest 99mTc-MIBI, (3) 201Tl rest-redistribution single-photon emission tomography, (4) [18F]FDG positron emission tomography. The left ventricle was devided into 11 segments on matched tomographic images. The segment with the highest activity at stress was taken as the reference (activity=100%). Perfusion defects at 99mTc-MIBI rest were classified as severe (activity<50%), moderate (activity 50%-60%) or mild (activity 60%-85%). Uptakes of [18F]FDG and rest-redistributed 201Tl were recognized as significant if they exceeded 50% of that in the reference segment. Among the 33 segments with severe 99mTc-MIBI rest perfusion defects, 21 had significant [18F]FDG and 10 significant rest-redistributed 201Tl uptake. As regards the 37 segments with moderate defects, [18F]FDG was present in 29 and 201Tl in 31, while of the 134 segments with mild defects, 128 showed [18F]FDG uptake, and 131, 201Tl uptake. In conclusion, there is an inverse relationship between the severity of 99mTc-MIBI perfusion defects and the uptake of rest-redistributed 201Tl and [18F]FDG. Both tracers are adequate markers of viability in mild and moderate defects; in severe defects 201Tl might underestimate the presence of viability as assessed by [18F]FDG.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8575482     DOI: 10.1007/bf00801618

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  31 in total

1.  Assessing inter-rater reliability for rating scales: resolving some basic issues.

Authors:  D V Cicchetti
Journal:  Br J Psychiatry       Date:  1976-11       Impact factor: 9.319

2.  Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.

Authors:  R O Bonow; V Dilsizian
Journal:  J Nucl Med       Date:  1992-05       Impact factor: 10.057

Review 3.  The clinical role of metabolic imaging of the heart by positron emission tomography.

Authors:  M Schwaiger; R Hicks
Journal:  J Nucl Med       Date:  1991-04       Impact factor: 10.057

4.  Quantitative rotational tomography with 201Tl and 99mTc 2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease.

Authors:  J K Kahn; I McGhie; M S Akers; M N Sills; T L Faber; P V Kulkarni; J T Willerson; J R Corbett
Journal:  Circulation       Date:  1989-06       Impact factor: 29.690

5.  Use of thallium-201 redistribution scintigraphy in the preoperative differentiation of reversible and nonreversible myocardial asynergy.

Authors:  A Rozanski; D S Berman; R Gray; R Levy; M Raymond; J Maddahi; N Pantaleo; A D Waxman; H J Swan; J Matloff
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

6.  Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.

Authors:  C Altehoefer; J vom Dahl; U Buell; R Uebis; E Kleinhans; P Hanrath
Journal:  Eur J Nucl Med       Date:  1994-01

7.  Prognostic value of normal technetium-99m-sestamibi cardiac imaging.

Authors:  K A Brown; E Altland; M Rowen
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

Review 8.  Myocardial perfusion imaging with thallium-201.

Authors:  G A Beller
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

9.  When is myocardial viability an important clinical issue?

Authors:  A S Iskandrian; J Heo; C Stanberry
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

10.  Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.

Authors:  G Lucignani; G Paolini; C Landoni; M Zuccari; G Paganelli; L Galli; G Di Credico; G Vanoli; C Rossetti; M A Mariani
Journal:  Eur J Nucl Med       Date:  1992
View more
  5 in total

Review 1.  Fluorine-18-deoxyglucose SPECT and coincidence imaging for myocardial viability: Clinical and technologic issues.

Authors:  V Dilsizian; S L Bacharach; M M Khin; M F Smith
Journal:  J Nucl Cardiol       Date:  2001 Jan-Feb       Impact factor: 5.952

Review 2.  Single photon emission computed tomography perfusion imaging for assessment of myocardial viability and management of heart failure.

Authors:  Steven Burrell; Sharmila Dorbala; Marcelo F Di Carli
Journal:  Curr Cardiol Rep       Date:  2003-01       Impact factor: 2.931

3.  Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction.

Authors:  K Shimada; Y Sakanoue; Y Kobayashi; S Ehara; M Hirose; Y Nakamura; D Fukuda; H Yamagishi; M Yoshiyama; K Takeuchi; J Yoshikawa
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

Review 4.  Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.

Authors:  J J Bax; F C Visser; A van Lingen; J H Cornel; P M Fioretti; E E van der Wall
Journal:  Int J Card Imaging       Date:  1997-04

Review 5.  Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability.

Authors:  M P Sandler; J A Patton
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.